Cataplexy Drugs Market Analysis

The market is segmented by drug type into central nervous system stimulants, sodium oxybate, tricyclic antidepressants, and others, out of which, the sodium oxybate segment is anticipated to witness the highest growth in the global cataplexy drugs market on account of the high effectiveness of this drug for treating cataplexy and daytime extreme sleepiness. Along with these, rising awareness about the benefits of sodium oxybate among people, is also projected to boost the growth of the market segment in the coming years. Additionally, on the basis of distribution channel, the segment for hospital pharmacies is assessed to grab the largest share during the forecast period, which can be credited to the fact that a hospital facility promotes frequent interactions of prescriber and other health professionals and improved input in making efficient drugs related decisions. 

Our in-depth analysis of the global cataplexy drugs market includes the following segments